Stay updated with breaking news from Evomic Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The industry is predicted to experience a notable expansion with a predicted global diagnostic exosome biomarkers market demand of US$ 196.8 million by 2023. The diagnostic exosome biomarkers sales are anticipated to thrive at a healthy CAGR of 16.3% between 2023 and 2033. A valuation of US$ 888.5 million is predict...
Exosome Diagnostics and Treatment Market is expected to reach US$ 358.91 Mn by 2027 With Aethlon Medical, Inc., Therapeutic Solutions International, Inc.,
ResearchAndMarkets.com’s offering. Exosome-related technologies have been developing rapidly over the past few years and substantial growth is expected for the market as they get integrated into the fields of liquid biopsy, precision medicine and regenerative medicine. In particular, cancer derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely useful source of biomarkers for use in cancer detection, diagnosis, and therapeutic selection. The cargo contained within exosomes can offer prognostic information for...